Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

Fractional lasers seem effective and safe for treating hair loss, but more research is needed to find the best treatment methods.

Postpartum depression is linked to changes in brain chemicals, inflammation, stress, and certain genes, and can potentially be identified by markers like specific steroids, serotonin levels, and vitamin D levels.

Laser treatment increases hair density and thickness safely in women with hair loss.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Trichotillomania, a disorder where people compulsively pull out their own hair, often starts around age 12, is more common in adult females, and can be treated with behavior therapy and medication.

Traditional treatment for pediatric alopecia areata is most effective and should be first choice.

An unusual growth of Leydig cells in a woman's ovaries caused her excessive hair growth, which was treated successfully with surgery.

Acyclovir cream may slow down hair growth, suggesting it could be a new treatment for excessive hairiness.

Hirsutism is often caused by high male hormone levels and can be treated with lifestyle changes and medications.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.

New effective scar treatments are urgently needed due to the current options' limited success.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Women with PCOS are more likely to suffer from depression, anxiety, and stress.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Oral minoxidil 5 mg daily increases hair growth safely in men with hair loss, with minor side effects.

Recognizing and managing skin-related psychiatric disorders in children is crucial for effective treatment.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

PCOS lowers quality of life, causing issues like obesity, infertility, and menstrual problems.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

A rare benign skin tumor showed unusual features of sebaceous and sweat glands, important for correct diagnosis.

Menopause can cause skin issues, and seeing a dermatologist helps.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.